#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein antibodies positive Emphysema Small cell lung cancer extensive stage Acquired C1 inhibitor deficiency Infective uveitis Penile cancer Loss of consciousness Oesophageal squamous cell carcinoma stage II Myocarditis Desmoid tumour Non-small cell lung cancer Gaucher's disease type III Myelodysplastic syndrome Non-small cell lung cancer recurrent Thermal burn More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome Amyotrophic lateral sclerosis – Treatment Propionic acidaemia – Basic Information Hepatic angiosarcoma X-linked lymphoproliferative syndrome – Treatment Chordoma – Treatment Sjogren’s syndrome – Basic Information Retinitis pigmentosa Alveolar rhabdomyosarcoma – Treatment Fragile X syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tas3351 Erythromycin Lactobionate Citalopram Tipiracil Loperamide A/(H3N2)-LIKE VIRUS ANTIGEN Apixaban VANADIUM OXIDE SULFATE Potassium Chloride Ngm707 Ofloxacin Hydrochloride Carbamazepine Oritavancin SARACATINIB Entrectinib AB521 Ondansetron Hydrochloride Quizartinib Dihydrochloride Gandotinib Cft1946 More therapies…

    Learn about Your Condition

    Anal cancer metastatic Femoral hernia Glioma Abdominal wall pain Diabetic foot infection Invasive breast carcinoma Rectal cancer stage II Neuroendocrine carcinoma Adenovirus infection Desmoplastic melanoma Relapsing multiple sclerosis Lyme disease Bone marrow failure Osteomyelitis acute Lymphocyte adoptive therapy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Prostate cancer

  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Dexamethasone Phosphate
    • Apalutamide
    • Enzalutamide
    Sweden

  • A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

    Recruiting

    3 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Saruparib
    • Abiraterone Acetate
    Austria Belgium Finland France Germany Hungary +5

  • Study of xaluritamig plus abiraterone for men with metastatic castration-resistant prostate cancer who have not received chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Abiraterone Acetate
    • Cabazitaxel
    • Xaluritamig
    Austria Belgium France Germany Greece Italy +3

  • A Study of GSK5458514 Alone or With Other Cancer Drugs in Adults With Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • GSK5458514
    France Spain

  • A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • ABIRATERONE DECANOATE
    • Abiraterone Acetate
    • Prednisolone
    France Germany Italy Poland Spain

  • Study on Erectile Dysfunction Recovery in Prostate Cancer Patients Using Relugolix

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Relugolix
    Italy
1 2 3 … 17
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!